CDD-1733

• Description :

  CDD-1733 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 12 nM. CDD-1733 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants[1].

• UNSPSC :

  12352005

• Target :

  SARS-CoV

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-anti-virus

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/cdd-1733.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(NC)[C@@](C1)([H])C[C@]1([H])N2C(C3=C(C=CC=C4)C4=CN=C3)=NC5=C2C(C(N[C@@H](CCC)C6=CC=C(C(F)(F)F)C=C6)=O)=CC=C5

• Molecular Formula :

  C34H32F3N5O2

• Molecular Weight :

  599.65

• References & Citations :

  [1]Ravikumar Jimmidi, et al. DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors. Commun Chem. 2023 Aug 4;6 (1) :164.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [2894104-33-5]